
Benzodiazepine Prescriptions Fell 26.7% Over a Decade, Study Finds
A Rutgers-led analysis of 1.1 billion fills found dispensing of Xanax, Valium and similar sedatives dropped from 7.5% to 5.5% of the population.
Evidence-based articles, treatment guides, and the latest news in addiction recovery and mental health.

A Rutgers-led analysis of 1.1 billion fills found dispensing of Xanax, Valium and similar sedatives dropped from 7.5% to 5.5% of the population.

Gov. Gavin Newsom vetoed Senate Bill 903, which would have barred companies from offering or advertising chatbot-delivered therapy to Californians.

The EEOC says the shipbuilder withdrew job offers from five applicants who take prescribed buprenorphine, violating the Americans with Disabilities Act.

Massachusetts health officials now say even moderate drinking can raise the risk of cancer, high blood pressure and heart disease, going further than federal advice.

Jerry Jones III, a former emergency physician, admitted trading buprenorphine and stimulant prescriptions worth nearly $295,000 in mobile payments.

Minnesota's health department launched MN-OD-ALERTS, which uses near-real-time ambulance and hospital data to flag opioid overdose spikes and warn local agencies.

In a pilot study, adults in addiction treatment reported lower cravings after music therapy sessions, with measurable shifts in EEG brain activity.

Arizona Attorney General Kris Mayes filed a consumer fraud lawsuit accusing Express Scripts and Optum of steering opioid prescriptions for profit.

Clear Scientific's CS-1103, a first-in-class sequestrant, accelerated fentanyl clearance into urine 25-fold in a 16-person Phase 2 trial. Phase 3 is set for 2027.